Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

Friday’s trading has closed, but GILD is being traded in the after-hours session. After-Hours quote »
85.14
Delayed Data
As of 4:00pm ET
 -1.54 / -1.78%
Today’s Change
81.89
Today|||52-Week Range
123.37
-15.86%
Year-to-Date

Today’s Trading

Previous close86.68
Today’s open86.68
Day’s range84.45 - 88.02
Volume15,732,823
Average volume (3 months)11,252,662
Market cap$124.9B
Dividend yield2.02%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+50.54%
Earnings growth (next 5 years)+6.70%
Revenue growth (last year)+121.81%
P/E ratio7.8
Price/Sales6.24
Price/Book8.42

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-4.87-3.25%
BIIBBiogen-9.41-3.44%
BXLTBaxalta Inc-0.91-2.34%
BAXBaxter International...-0.80-2.09%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateApril 19, 2016
EPS forecast (this quarter)$2.99
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President, Chief Operating Officer &
Director
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

Partner Offers